Sign in
4

Changes in Ownership

PMV Pharmaceuticals, Inc. Filed Acc 0001209191-21-038419

President and CEO acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Mack David Henry · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-05-20 Exercise or conversion : show line 1 in the form +10,000 $0.53 $5,300 12,470 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-05-21 Exercise or conversion : show line 2 in the form Stock Option (right to buy) −10,000 475,074 D
Loading xslF345X03/doc4.xml…